|
Date |
Contents |
|
2019 |
Company Name Changed to ¡®Bioinnotis¡¯ |
|
2018 |
Complex Minoxyl has been technology transfer to HDP. |
|
2018 |
Complex Minoxyl has been approved in KFDA |
|
2018 |
Pemirosal tablet 5mg, 10mg has been approved in KEDA |
|
2017 |
Pemirosal tablet 5mg, 10mg has been technology transfer to HDP. |
|
2017 |
Lacopat tablet 50mg, 100mg has been approved in KFDA. |
|
2017 |
Dimantin tablet 5mg, 10mg has been technology transfer to HDP. |
|
2017 |
Dimantin tablet 5mg, 10mg has been approved in KFDA |
|
2016 |
Lacopat tablet 50mg, 100mg has been technology transfer to HDP. |
|
2015 |
DistricAth® has been approved in Thailand |
|
2015 |
Minoxyl solution 5% has been approved in Myanmar |
|
2014 |
Mooplas-F solution has been approved in Mongolia |
|
2014 |
Minoxyl solution 5% was submitted in Cambodia |
|
2014 |
Moolpas-F and Bumooly-S have been approved from US FDA |
|
2014 |
Mirtapin (Mirtazapine) tablet 15mg has been approved in Hong Kong |
|
2014 |
Mirap (Pramipexole) SR tablet 0.75mg was submitted in TFDA |
|
2014 |
Olapin (Olanzapine) tablet 5mg and 10mg have been approved in Hong Kong |
|
2014 |
Varosc (Amlodipine) tablet has been approved in Cambodia |
|
2014 |
Signed license-out and supply agreement of Surfolase (Acebrophyline) capsule with Novotek, China |
|
2013 |
Choline alfoscerate SR has been selected as one of projects supported by Ministry of Health and Welfare |
|
2013 |
Signed an exporting contract of Varosc tablet with Cambodia |
|
2013 |
Signed an exporting contract of Minoxyl solution 5% with Myanmar |
|
2013 |
Signed an exporting contract with Hong Kong (Olanzapine, Mirtazapine) |
|
2013 |
Registered of patent for Choline Alfoscerate SR and Alfoscerate IR |
|
2013 |
Registered of patent for Ibandronate |
|
2012 |
Signed an exporting contract with Yemen (6 products including Drovon tablet) |
|
2012 |
Signed a technology transfer agreement of Pramipexole SR with ¡°AET¡± |
|
2012 |
Signed a technology transfer agreement of Ibandronate with 15 domestic companies |
|
2012 |
Signed a technology transfer agreement of Levetiracetam with 3 domestic companies |
|
2012 |
Moolpas-F solution is approved in Hong Kong |
|
2011 |
Signed a technology transfer agreement Tamirin SR (Galantamine SR) with CLOSTER PHARMA S.A for the territory in middle & southern America & Spain, Portugal |
|
2011 |
Minoxyl(minoxidil) solution 5%, Varosc (amlodipine) tablet are approved in Vietnam |
|
2011 |
Signed a technology transfer agreement of Olanzapine with 2 domestic companies |
|
2011 |
Signed a technology transfer agreement of Pitavastatin with 11 domestic companies |
|
2011 |
Established Global Business Division in charge of entire global business from registration to export on behalf of Hyundai Pharm. |
|
2010 |
Signed a technology transfer agreement of Adefovir with 6 domestic companies |
|
2010 |
Signed a technology transfer agreement of Lamivudine with 2 domestic companies |
|
2010 |
Signed a technology transfer agreement of Telmisartan with Kolmar |
|
2010 |
Signed a technology transfer agreement of Olmesartan with Kolon |
|
2009 |
Founded Biopharmartis. |
|